Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of SPAG9 mRNA | affects expression | 21346803
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of SPAG9 mRNA | increases expression | 18687144
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of SPAG9 mRNA | increases expression | 20127859
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of SPAG9 mRNA | increases expression | 20106945
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SPAG9 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of SPAG9 mRNA | decreases expression | 18175754
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of SPAG9 mRNA | affects expression | 17440010
|
D019772 |
Topotecan |
SPAG9 protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
D014212 |
Tretinoin |
SPAG9 protein promotes the reaction [Tretinoin results in increased phosphorylation of MAPK8 protein] | increases phosphorylation|increases reaction | 16619266
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [SPAG9 protein binds to GNA13 protein] | affects binding|increases reaction | 16619266
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of SPAG9 protein | increases expression | 16619266
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.34 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.02 | 20464547 20127859 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.76 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.76 | 16434500 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.78 | 15955085 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.33 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.19 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.30 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.39 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.64 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.67 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.67 | 16206674 16197459 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.08 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.08 | 16166294 16873071 16443354 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.88 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.48 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.09 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.09 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.74 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.74 | 16096774 16051514 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.20 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.03 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.03 | 12371664 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.88 | 16129372 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.26 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.26 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.48 | 16461808 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.01 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.74 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.96 | 17035595 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.83 | 10589399 9125849 17551590 14991402 9224671 16925845 9211117 9664655 9142499 8800419 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.28 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.51 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.96 | 16285004 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
4.14 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
4.14 | 15131321 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.68 | 12083418 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.78 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.23 | 16569247 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.05 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.73 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.25 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.25 | 20131406 19236843 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.57 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
9.57 | 17994277 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.50 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.13 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.32 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.48 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.98 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.98 | 9664655 14991402 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.65 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.71 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.25 | 18467677 19772884 16221962 19176532 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
6.06 | 17440010 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.37 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.83 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.38 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.16 | 10903974 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.74 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
7.74 | 14714311 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.02 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.11 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.76 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.44 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.85 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.85 | 12371664 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.86 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.90 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.10 | 16294345 19850784 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.28 | 17107899 16935935 15748426 17368321 17339181 19225113 16140955 17301526 16766008 19029980 16891316 17506722 17294898 17649720 17712046 12679006 16823087 16788101 19075265 19035177 17361223 19642359 17217047 9834237 16331271 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.45 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.39 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.39 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.77 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.77 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.77 | 20007298 16377806 15890375 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.66 | 2876786 6135515 2876784 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
4.28 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
1.56 | 18816296 20869020 18569708 20064080 17053015 20135361 18520028 6695378 20464547 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.28 | 14737004 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.85 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.96 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.68 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.25 | 16966607 16166281 18303189 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.11 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.35 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.76 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.19 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.21 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.10 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.15 | 18551238 7678174 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.73 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.73 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.73 | 16594593 16946489 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.76 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.47 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.02 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.18 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
3.94 | 15176712 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.85 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.62 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.40 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.07 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.52 | 15976015 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
5.15 | 10923243 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.40 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.17 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.17 | 18760546 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.82 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.29 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.08 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.09 | 15814490 17365031 17975199 17322281 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.47 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.32 | 16116481 16283617 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.67 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.97 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
5.97 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.39 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.39 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.18 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.98 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.34 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.21 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.21 | 17053015 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.60 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.87 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.93 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.30 | 1336536 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.29 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.15 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.76 | 17120751 |